![Roger Perlmutter](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Roger Perlmutter
Vorstandsvorsitzender bei
EIKON THERAPEUTICS, INC.
Vermögen: 18 Mio $ am 31.08.2026
Profil
Dr. Roger M.
Perlmutter is an Independent Director at NGM Biopharmaceuticals, Inc., a Chairman & Chief Executive Officer at Eikon Therapeutics, Inc., an Independent Director at Insitro, Inc., a Chairman at The Reed Institute, a Member at American Academy of Arts & Sciences and a Science Partner at The Column Group LLC.
He is on the Board of Directors at NGM Biopharmaceuticals, Inc., Insitro, Inc., Exonics Therapeutics, Inc. and Institute for Systems Biology.
Dr. Perlmutter was previously employed as an Executive Vice President by Merck & Co., Inc., an Independent Director by Ablynx NV, a Non-Executive Director by Nxera Pharma UK Ltd., an Executive VP & Head-Research & Development by Amgen, Inc., an Independent Director by StemCells, Inc., a Non-Executive Director by Merck Research Laboratories Massachusetts LLC, an EVP-Worldwide Basic & Preclinical Research by Merck & Co., Inc., a Chairman-Immunology Department & Professor by University of Washington, a President & Director by Alantos Pharmaceuticals Holding, Inc., and a President by The American Association of Immunologists.
He also served on the board at Immune Design Corp.
and The Irvington Institute for Immunological Research.
He received his undergraduate degree from The Reed Institute and a doctorate degree from Washington University in St. Louis.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 02.03.2026 | 1’760’713 ( 3.25% ) | 18 Mio $ | 31.08.2026 |
Aktive Positionen von Roger Perlmutter
| Unternehmen | Position | Beginn |
|---|---|---|
| EIKON THERAPEUTICS, INC. | Vorstandsvorsitzender | 01.05.2021 |
| NGM BIOPHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 08.06.2021 |
Insitro, Inc.
 Insitro, Inc. BiotechnologyHealth Technology Operates as a biology based AI therapeutics company | Direktor/Vorstandsmitglied | 01.10.2020 |
Exonics Therapeutics, Inc.
 Exonics Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for neuromuscular diseases | Direktor/Vorstandsmitglied | 30.01.2018 |
The Column Group LLC
 The Column Group LLC Investment ManagersFinance TCG invests in companies located in the United States. The firm focuses on drug discovery, biology, chemistry, and technology sectors. It provides financing for early and later stage capital requirements with an investment size of USD 50 - 60 million. | Corporate Officer/Principal | - |
The Reed Institute
 The Reed Institute Other Consumer ServicesConsumer Services Functions as a College/University | Vorsitzender | 21.06.2012 |
Institute for Systems Biology
 Institute for Systems Biology Miscellaneous Commercial ServicesCommercial Services Provides integration of technology, computation, biology and medicine | Direktor/Vorstandsmitglied | 24.05.2013 |
American Academy of Arts & Sciences
 American Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services Operates as organization which honours excellence and convenes leaders | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Roger Perlmutter
| Unternehmen | Position | Ende |
|---|---|---|
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Präsident | 01.01.2021 |
| ░░░░░ ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Roger Perlmutter
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
95
Beziehungen ersten Grades
20
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 20 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
StemCells, Inc.
 StemCells, Inc. BiotechnologyHealth Technology Researches and develops stem cell therapeutics | Health Technology |
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Washington University in St. Louis
 Washington University in St. Louis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alantos Pharmaceuticals Holding, Inc.
 Alantos Pharmaceuticals Holding, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
NGM Biopharmaceuticals, Inc.
 NGM Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel & life-changing medicines | Health Technology |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Reed Institute
The Reed Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ablynx NV
 Ablynx NV BiotechnologyHealth Technology Develops and produces antibodies | Health Technology |
Institute for Systems Biology
Institute for Systems Biology Miscellaneous Commercial ServicesCommercial Services Provides integration of technology, computation, biology and medicine | Commercial Services |
American Academy of Arts & Sciences
American Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services Operates as organization which honours excellence and convenes leaders | Commercial Services |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
The Irvington Institute for Immunological Research
 The Irvington Institute for Immunological Research Miscellaneous Commercial ServicesCommercial Services Engages in researching and developing biotechnology | Commercial Services |
The American Association of Immunologists
 The American Association of Immunologists Miscellaneous Commercial ServicesCommercial Services The American Association of Immunologists is a professional organization dedicated to advancing immunology research, education, and public understanding of the immune system. The non-profit company is based in Bethesda, MD. It supports the immunology community through programs and resources, including annual meetings, summer courses, specialized programs, career development initiatives, fellowships, awards, travel grants, and mentoring resources. The association publishes two journals, The Journal of Immunology and ImmunoHorizons, and engages in advocacy and public policy related to vaccine policy, NIH funding, and research priorities. It also promotes diversity and inclusion through committees and initiatives for underrepresented minority scientists and provides educational content, public outreach, and advocacy resources. | Commercial Services |
Nxera Pharma UK Ltd.
 Nxera Pharma UK Ltd. Pharmaceuticals: MajorHealth Technology Designs and develops new medicines targeting G protein-coupled receptors | Health Technology |
The Column Group LLC
The Column Group LLC Investment ManagersFinance TCG invests in companies located in the United States. The firm focuses on drug discovery, biology, chemistry, and technology sectors. It provides financing for early and later stage capital requirements with an investment size of USD 50 - 60 million. | Finance |
Immune Design Corp.
 Immune Design Corp. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical and clinical-stage immunotherapy company | Health Technology |
Exonics Therapeutics, Inc.
Exonics Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for neuromuscular diseases | Health Technology |
Insitro, Inc.
Insitro, Inc. BiotechnologyHealth Technology Operates as a biology based AI therapeutics company | Health Technology |
Eikon Therapeutics, Inc.
 Eikon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical biopharmaceutical company that dedicated to inventing and developing of breakthrough therapeutics | Health Technology |
